Elevated plasma SDF-1 was significantly associated with an increased risk of recurrent stroke and cardiovascular events at one year only in ischemic stroke patients with diabetes mellitus, but not in those without diabetes mellitus. Here, CXCL12 is linked to ischemic stroke.